Browse Related Topics For:

The United States Food and Drug Administration

941
Pharmaceutical Industry
658
Medical Devices
519
Prescription Drugs
364
Biosimilars
338
Food Labeling
296
Healthcare
276
Patents
250
Pharmaceutical Patents
236
Generic Drugs
227
FDCA
226
BPCIA
218
Manufacturers
215
Food Safety
211
Food Manufacturers
191
Draft Guidance
182
Popular
181
Patent Litigation
179
Affordable Care Act
171
HHS
171
Patent Infringement
152
CMS
151
Biologics
138
ANDA
137
Off-Label Promotion
136
Amgen
133
FTC
131
Labeling
129
FSMA
128
Advertising
127
False Advertising
126
SCOTUS
124
Preemption
117
Medicare
109
GMO
107
Sandoz
104
First Amendment
102
Sandoz v Amgen
101
Medicaid
100
Cybersecurity
99
Hatch-Waxman
97
USDA
96
Class Action
96
Health Care Providers
93
FDA Approval
87
Biotechnology
86
Clinical Trials
86
Life Sciences
82
EPA
82
Nutrition Facts Labels
79
Legislative Agendas
77
Marketing
75
Comment Period
75
Off-Label Use
67
21st Century Cures Initiative
64
Final Rules
63
NIH
62
DOJ
62
Preliminary Injunctions
60
Patent Dance
60
Warning Labels
59
Trump Administration
58
Pharmacies
57
Appeals
57
Enforcement Actions
55
Amarin
55
Final Guidance
55
Misbranding
55
Public Comment
53
HIPAA
53
Product Labels
52
Commercial Marketing
52
Drug Compounding
50
Dietary Supplements
50
False Claims Act (FCA)
50
Lanham Act
50
New Guidance
50
Restaurant Industry
49
CDC
49
Hospitals
47
Failure To Warn
47
Natural Products
46
Apotex
45
POM Wonderful
44
Health Insurance
44
Mobile Apps
43
Free Speech
42
Physicians
41
FFDCA
40
Food Contamination
39
510(k) RTA
38
All Natural
38
Food Marketing
38
Laboratory Developed Tests
38
Proposed Legislation
38
Reporting Requirements
37
Coca Cola
37
Corporate Counsel
37
Drug Pricing
36
Product Recalls
36
Warning Letters
35
Menu-Labeling
35
POM Wonderful v Coca Cola
34
aBLA
34
E-Cigarettes
34
EU
34
FCC
34
Healthcare Reform
34
Notice Requirements
34
Social Media
33
Chemicals
33
FD&C Act
33
Medical Research
33
Premarket Approval Applications
33
Proposed Regulation
33
Risk Management
32
Patent-in-Suit
32
Safe Harbors
32
Toxic Substances Control Act (TSCA)
31
HELP
30
Commercial Speech
30
GAO
30
Nanotechnology
29
Food Recalls
29
Pending Legislation
29
Putative Class Actions
28
Data Protection
28
Diagnostic Tests
28
FIFRA
28
Mobile Health Apps
28
Public Meetings
27
Compliance
27
Health Information Technologies
27
Medicare Part D
27
NLEA
27
OIG
27
Software
27
Unfair Competition
26
21st Century Cures Act
26
Enforcement
26
FDASIA
26
Imports
26
Regulatory Agenda
26
Supply Chain
26
Telemedicine
25
Cancer
25
Congressional Investigations & Hearings
25
Drug Safety
25
Product Defects
25
Summary Judgment
24
3D Printing
24
AbbVie
24
Barack Obama
24
Clinical Laboratories
24
Dismissals
24
Intellectual Property Protection
24
OSTP
24
Personalized Medicine
24
Settlement
24
Technology
24
USPTO
23
Design Defects
23
Fraud
23
Innovation
23
IRS
23
mHealth
23
Orphan Drugs
23
Unfair or Deceptive Trade Practices
22
CHIP
22
Cosmetics
22
Johnson & Johnson
22
Multidistrict Litigation
22
Mylan Pharmaceuticals
22
Pesticides
22
Research and Development
21
Biologics Price Competition and Innovation Act of 2009
21
Citizen Petitions
21
Digital Health
21
FDA Warning Letters
21
Misleading Statements
21
Obama Administration
21
ONC
21
SEC
20
Declaratory Judgments
20
EHR
20
Hospira
20
Medicare Part B
20
OMB
19
CERCLA
19
CGMP
19
Criminal Prosecution
19
Disclosure Requirements
19
Grocery Stores
19
Hackers
19
Jurisdiction
19
Patent Applications
19
PHRMA
19
Public Health
19
Public Health Service Act
19
Recordkeeping Requirements
19
Regulatory Oversight
18
Class Certification
18
DSCSA
18
Farms
18
PHI
18
Product Packaging
18
RCRA
18
Teva Pharmaceuticals
18
Wine & Alcohol
17
Caronia
17
CLIA
17
Contraceptive Coverage Mandate
17
DNA
17
Federal Budget
17
Federal Register
17
FSVP
17
Medtronic
17
Mental Health
17
Motion to Dismiss
17
New Legislation
17
Obviousness
17
Regulatory Standards
17
Retailers
17
Risk Assessment
17
Standing
17
Whistleblowers
16
Adverse Events
16
Antitrust Litigation
16
App Developers
16
Clean Air Act
16
Clean Water Act
16
Consumer Product Safety Commission (CPSC)
16
Data Breach
16
GlaxoSmithKline
16
Health Insurance Exchanges
16
HRSA
16
Medicare Access and CHIP Reauthorization (MACRA)
16
Misleading Impressions
16
Prior Art
16
Qui Tam
16
Section 340B
16
Substance Abuse
16
Tobacco
16
Trademarks
15
Animal Food
15
Bayer
15
Contraceptives
15
DQSA
15
Fast-Food Industry
15
Injunctive Relief
15
Inter Partes Review (IPR) Proceeding
15
Medicare Advantage
15
NIST
15
OSHA
15
Personal Care Products
15
Tobacco Regulations
15
Trans Fat
15
Unique Device Identifiers
15
User Fees
15
Zika
14
Attorney Generals
14
Birth Defects
14
Data Collection
14
Data Security
14
DEA
14
Discovery
14
DOL
14
Evaporated Cane Juice
14
Genetic Testing
14
Janssen Pharmaceuticals
14
Legislative Committees
14
Marijuana
14
Organic
14
Patent Invalidity
14
Product Exclusivity
14
Reverse Payment Settlement Agreements
14
Social Networks
14
Wellness Programs
13
Certiorari
13
China
13
Controlled Substances Act
13
Cyber Attacks
13
Drug & Alcohol Abuse
13
Electronic Medical Records
13
Negligence
13
OCR
13
Opioid
13
Patient Safety
13
Personal Jurisdiction
13
PHSA
13
Pleading Standards
13
PLIVA v Mensing
13
Precision Medicine Initiative (PMI)
13
Repeal
13
Rulemaking Process
12
23andMe
12
ACOs
12
Children's Products
12
Civil Monetary Penalty
12
Distributors
12
Exemptions
12
Federal Funding
12
GRAS
12
Investigational New Drug procedures (IND)
12
Medical Device Accessories
12
Medical Marijuana
12
Merck
12
Misrepresentation
12
Nutritional Supplements
12
Orange Book
12
PDUFA
12
Pfizer
12
Public Hearing
12
REMS
12
Retail Market
12
World Health Organization
11
Administrative Procedure Act
11
Allergan Inc
11
America Invents Act
11
Canada
11
Causation
11
Foreign Suppliers
11
FTC v Actavis
11
General Mills
11
Healthcare Facilities
11
Informed Consent
11
Inspections
11
IRIS
11
Learned Intermediary
11
Long Term Care Facilities
11
Medicaid Expansion
11
New Regulations
11
OECD
11
Prescription Drug Coverage
11
Primary Jurisdiction Doctrine
11
Professional Conferences
11
Salmonella
11
Scientific Research
11
Transvaginal Mesh
11
Vaccinations
11
Veterinary Products
10
Additive Manufacturing
10
Anti-Kickback Statute
10
Antibiotics
10
Black Box Warnings
10
DHS
10
Dole Food
10
Drug Approvals
10
Drug Distribution
10
European Medicines Agency (EMA)
10
Expert Testimony
10
Fifth Amendment
10
Food Supply
10
Gluten-Free
10
Healthcare Fraud
10
Information Sharing
10
Infringement
10
Internet of Things
10
Interstate Commerce
10
Investors
10
MedPAC
10
Menu Rule
10
Mobile Devices
10
On-Sale Bar
10
Personally Identifiable Information
10
Risk Mitigation
10
Safety Precautions
10
Side Effects
10
Telehealth
10
Transparency
10
Young Lawyers
9
Actavis Inc.
9
Antitrust Violations
9
Appropriations Bill
9
Breach of Warranty
9
CLRA
9
Copyright
9
Cyber Threats
9
Databases
9
Employee Benefits
9
ERISA
9
European Food Safety Authority (EFSA)
9
Excise Tax
9
Exports
9
FOIA
9
Guidance Update
9
Home Health Care
9
Investigational Device Exemptions
9
Listeria
9
Medical Device Data System
9
NAD
9
Patent Trial and Appeal Board
9
Patients
9
Pay-For-Delay
9
Physician Medicare Reimbursements
9
Privacy Concerns
9
Sherman Act
9
Shipping
9
Sunshine Act
9
Wage and Hour
9
Wearable Technology
8
Abbott Laboratories
8
Acquisitions
8
Animal Drugs
8
Anti-Competitive
8
Beverage Manufacturers
8
Celebrity Endorsements
8
Congressional Committees
8
Cost-Sharing
8
Customs and Border Protection
8
Ebola
8
Eli Lilly
8
European Commission
8
Federal Rules of Civil Procedure
8
Genetically Engineered Seed
8
Google
8
Government Shutdown
8
Homeopathic Remedies
8
Human Genes
8
Inadequate Warning
8
Interchangeability
8
Internet
8
Investigational New Drug Application (IND)
8
Medical Malpractice
8
Mergers
8
Mobile Medical Applications
8
Modification
8
Novartis
8
Outsourcing
8
Petition for Writ of Certiorari
8
Pregnancy
8
Salmon
8
SAMHSA
8
Sanitary Food Transportation Act (SFTA)
8
School Lunch Programs
8
Securities Litigation
8
Skilled Nursing Facility
8
SNUR
8
Soda Tax
8
Stark Law
8
Stem cells
8
The Common Rule
8
Trucking Industry
7
Advisory Committee
7
Amended Regulation
7
Amicus Briefs
7
Article III
7
Classen Immunotherapies
7
Clean Power Plan
7
Consumer Fraud
7
COPPA
7
Covered Entities
7
Department of Transportation (DOT)
7
Employer Mandates
7
Exclusivity
7
FCPA
7
FDA Commissioner
7
Food Allergies
7
General Wellness Devices
7
Genetically Engineered Animals
7
Gerber
7
HCEI
7
HITECH
7
Illegal Drugs
7
Importers
7
Infectious Diseases
7
Insurance Industry
7
IRB
7
Kellogg Company
7
Licensing Rules
7
Nanomaterials
7
Negligent Misrepresentation
7
Pain Management
7
Product Hopping
7
Proposition 65
7
Public Health Insurance Marketplace
7
Public Safety
7
Punitive Damages
7
Qualified Health Plans
7
Registration
7
Secretary of HHS
7
Securities Fraud
7
Toxic Chemicals
7
Trade Secrets
7
UK
7
Watson Pharmaceuticals
7
Websites
7
Whole Foods
7
Wrongful Death
6
ADA
6
American Medical Association
6
Amgen v Sandoz
6
Antibiotic Resistance
6
Antitrust Provisions
6
Biobased Chemicals
6
Bioengineering
6
Biopharmaceutical
6
Blue Bell Creameries
6
Brand
6
Breweries
6
Burwell v Hobby Lobby
6
Chobani Inc
6
Competition
6
ConAgra
6
Confidential Information
6
Controlled Substances
6
Data Privacy
6
Delays
6
Department of Veterans Affairs
6
EEOC
6
Elan Pharmaceuticals
6
Evidence
6
Executive Orders
6
False Statements
6
Fiduciary Duty
6
GDUFA
6
Government Investigations
6
Hobby Lobby
6
Human Genome Project
6
Indictments
6
Insider Trading
6
Kickbacks
6
Kim Kardashian
6
Legal Perspectives
6
Licenses
6
Manufacturing Defects
6
Mensing
6
Mutual Pharmaceuticals v Bartlett
6
OPDP
6
OPPS
6
OTC
6
Otsuka Pharmaceutical
6
Over-the-Counter Sales
6
Patient Privacy Rights
6
Personal Liability
6
Privacy Policy
6
Public Disclosure
6
Purple Book
6
Registration Requirement
6
Safety Standards
6
Samsung
6
Senate Confirmation Hearings
6
Shareholders
6
Smartphones
6
State Law Claims
6
Strict Liability
6
Subway
6
Suppliers
6
Tax Credits
6
Twitter
6
Twombly/Iqbal Pleading Standard
6
Unjust Enrichment
6
Waters of the United States
6
Wholesale
5
Animal Health
5
Attorney-Client Privilege
5
Audits
5
Australia
5
Big Data
5
Bodily Injury
5
Breach Notification Rule
5
Burden of Proof
5
Cadillac Tax
5
Celltrion
5
CEOs
5
Claim Construction
5
Climate Change
5
Contamination
5
Continuing Resolution
5
Corporate Officers
5
Cyber Crimes
5
Dairy Farmers
5
Disgorgement
5
Do Not Track
5
Durable Medical Equipment
5
EAP
5
Elder Issues
5
Endo Pharmaceuticals
5
ESRD
5
Facebook
5
Farm Animals
5
Farm Bill
5
Federal Rule 12(b)(6)
5
Food and Drug Administration Amendments Act (FDAAA)
5
Genetic Materials
5
Greenhouse Gas Emissions
5
Health Claims
5
Hospitality Industry
5
ICD-10
5
Injunctions
5
Liability Insurance
5
Marijuana Cultivation
5
Mass Tort Litigation
5
Monopolization
5
National Academy of Sciences (NAS)
5
National Cancer Moonshot
5
Nursing Homes
5
OFAC
5
Office of Chemical Safety & Pollution Prevention (OCSPP)
5
Omnicare
5
Open Enrollment
5
Park Doctrine
5
Patent Term Extensions
5
Patent-Eligible Subject Matter
5
Permanent Injunctions
5
Pharmacist
5
Presidential Elections
5
Product Development Protocols
5
Proposed Amendments
5
PSLRA
5
Reimbursements
5
Renewable Energy
5
Request For Information
5
Right of Publicity
5
Right to Try
5
Risk-Based Approaches
5
Sanctions
5
Scams
5
Scienter
5
Scientific Evidence
5
Seafood
5
Settlement Agreements
5
Small Business
5
Toxic Exposure
5
Training
5
Venture Capital
5
Verification Requirements
5
Veterans
5
Whistleblower Protection Policies
5
Wyeth
5
Yates Memorandum
4
Abortion
4
Allergan v Sandoz
4
American Health Care Act (AHCA)
4
Anheuser-Busch
4
Anti-Retaliation Provisions
4
Antimicrobials
4
APHIS
4
Baby Products
4
Beer
4
Best Practices
4
Biogen Idec
4
Boehringer
4
Breach of Duty
4
Carbon Nanotubes
4
CCIIO
4
Celiac Disease
4
Center for Drug Evaluation and Research (CDER)
4
Cephalon
4
Chipotle Grill
4
Commercial Truck Drivers
4
Conflicts of Interest
4
Congressional Review Act
4
Consumer Protection Act
4
Cyber Insurance
4
Damages
4
Data-Sharing
4
Daubert Standards
4
Declaratory Relief
4
Department of Agriculture
4
Department of Defense (DOD)
4
DOE
4
Drinking Water
4
Employer Liability Issues
4
European Court of Justice (ECJ)
4
Federal Contractors
4
Financial Conduct Authority (FCA)
4
FLSA
4
Foreign Manufacturers
4
FTC Act
4
Fungal Meningitis
4
Genentech
4
Generic
4
GNC
4
Hazardous Substances
4
Hazardous Waste
4
Health and Safety
4
Health IT
4
Health Safety
4
Hospice
4
Human Rights
4
Information Reports
4
Inpatient Prospective Payment System (IPPS)
4
Intellectual Property Litigation
4
Inventors
4
IP License
4
Jury Trial
4
Laboratories
4
Managed Care Contracts
4
Marijuana Related Businesses
4
Medical Device User Fee Program (MDUFA IV)
4
Medical Reimbursement
4
Memorandum of Understanding
4
Method Claims
4
Minors
4
Mootness
4
Native American Issues
4
Nestle
4
NFL
4
NIOSH
4
NLRB
4
No-AG Agreement
4
NPRM
4
Nurses
4
Oil & Gas
4
openFDA
4
Oral Argument
4
OxyContin
4
Patient-Specific
4
Penalties
4
Physician Fee Schedule
4
Physician SGR Formula
4
Post-Grant Review
4
Preventive Health Care
4
Private Right of Action
4
Proposed Rules
4
Quality Control Plan
4
Relators
4
Religion
4
Religious Freedom Restoration Act
4
RICO
4
Ripeness
4
Section 503
4
Securities Exchange Act
4
Slack-Fill Suits
4
Solicitor General
4
Starbucks
4
Startups
4
Statute of Limitations
4
Strategic Enforcement Plan
4
Subject Matter Jurisdiction
4
Subsidies
4
Telemarketing Sales Rule
4
U.S. Treasury
4
UAW
4
Unfair Competition Law (UCL)
4
Veterinarians
4
Wal-Mart
4
Webinars
4
Wireless Technology
4
WTO
3
Agricultural Sector
3
ALJ
3
All Writs Act
3
Alternative Payment Models (APM)
3
Amgen v Apotex
3
AMP v Myriad
3
Anti-Steering Rules
3
Applications
3
Arbitration
3
Asbestos
3
Ascertainable Class
3
AstraZeneca
3
Attorney's Fees
3
Automotive Industry
3
Aviation Industry
3
Biometric Information
3
Board of Directors
3
BPA
3
Breach of Contract
3
Bribery
3
Bristol-Myers Squibb
3
Capital Raising
3
Certifications
3
CFPB
3
Chevron Deference
3
Clear and Convincing Evidence
3
Clinical Laboratory Testing
3
Co-Op
3
Combination Products
3
Compensatory Damages
3
Competitive Bidding
3
Complete Genomics
3
Congressional Budget Office
3
Conversion
3
Corporate Integrity Agreement
3
Corrective Actions
3
Counterfeit Drugs
3
Crops
3
Cross-Border Transactions
3
Cybersecurity Framework
3
Data Integrity
3
Decriminalization of Marijuana
3
Derivation Proceeding
3
Direct to Consumer Sales
3
Disclaimers
3
Disclosure
3
Discussion Draft
3
Dispute Resolution
3
DMEPOS
3
Due Diligence
3
Due Process
3
EAR
3
ECHA
3
Electronic Health Record Incentives
3
Electronically Stored Information
3
Email
3
Employer Group Health Plans
3
Endangered Species Act (ESA)
3
Energy Sector
3
Enforcement Guidance
3
Enrollment
3
Environmental Policies
3
Ethics
3
Exclusive Dealing Agreements
3
FDAMA
3
Federal Question Jurisdiction
3
Fee-for-Service
3
Fees
3
Financial Institutions
3
Financial Markets
3
Flame Retardant
3
FMCSA
3
Food & Drug Regulations
3
Foreign Investment
3
Fracking
3
Franchises
3
Frito-Lay
3
General Electric
3
Genzyme
3
GINA
3
GMO Bans
3
Good Clinical Practices
3
GPOs
3
HCPCS
3
Healthcare.gov
3
HEAT
3
Hersheys
3
Hiring & Firing
3
HIV
3
Individual Mandate
3
Induced Infringement
3
Information Technology
3
Infrastructure
3
Innovator Liability
3
Inpatient Rehab Facilities
3
International Harmonization
3
Justice Scalia
3
Kraft
3
Lautenberg Act
3
Law Matters
3
License Agreements
3
Local Ordinance
3
Long-Term Care
3
Malware
3
Marketing Authorization Application
3
Materiality
3
Medical Foods
3
Medicare Modernization Act
3
Meningitis
3
Minimum Salary
3
Minimum Wage
3
Monsanto
3
Monster Energy Drinks
3
NAFTA
3
National Security
3
NLRA
3
Nominations
3
Notice Provisions
3
Notification Requirements
3
NRDC
3
Office for Human Research Protections (OHRP)
3
Online Advertisements
3
Online Platforms
3
Order to Stay
3
Outsourcing Facilities
3
Over-Time
3
PAMA
3
Par Pharmaceutical
3
Patient Prospective Payment System
3
PHMSA
3
Podcasts
3
Policies and Procedures
3
Policy Exclusions
3
Pollinators
3
Power Plants
3
Premiums
3
Presidential Nominations
3
Privacy Laws
3
Product Enhancements
3
Property Damage
3
Provider Payments
3
Public Schools
3
Publicly-Traded Companies
3
Rebates
3
Red Bull
3
Religious Exemption
3
Research Funding
3
Responsible Corporate Officer Doctrine
3
Reversal
3
Right to Privacy
3
Robocalling
3
Rule-of-Reason Analysis
3
Safety Inspections
3
Sales & Use Tax
3
Sanofi
3
Sealed Records
3
Securities
3
Securities Violations
3
SNDAs
3
Software Developers
3
Spectrum
3
Standard of Care
3
State Health Insurance Exchanges
3
State Law Tort Claims
3
Stock Drop Litigation
3
Surveillance
3
Takeda Pharmaceuticals
3
Tax Deductions
3
Tax Extenders
3
Tax Reform
3
TCPA
3
Technology Sector
3
Testing Requirements
3
Third-Party
3
Third-Party Service Provider
3
Tips
3
Tobacco Litigation
3
Trade Associations
3
Trade Policy
3
Trademark Infringement
3
Traumatic Brain Injuries
3
TRO
3
TTB
3
Two-Midnight Rule
3
UK Brexit
3
Universal Health Services Inc v United States ex rel Escobar
3
Waivers
3
Weight-Loss Products
3
Work Product Privilege
3
Working Groups
3
Yahoo!
3
YouTube
2
401k
2
Accreditation
2
Acquisition Agreements
2
Acquittals
2
Actual Injuries
2
Administrative Appointments
2
Administrative Stay
2
Advanced Notice of Proposed Rulemaking (ANPRM)
2
Aetna
2
Affirmative Defenses
2
AHRQ
2
Alcohol Beverage Control
2
Algorithms
2
Alzheimer's
2
Ambulatory Surgery Centers
2
American Cancer Society
2
Animal Testing
2
Antitrust Injuries
2
Appellate Review
2
Artificial Intelligence
2
Asia
2
Assisted Living Facility
2
ASTM
2
Bad Faith
2
Banks
2
Bellwether Verdicts
2
Benefit Plan Sponsors
2
Best Management Practices
2
Bifurcation
2
Bioproducts
2
BIS
2
Blue Diamond Growers
2
BPCI
2
BRCA
2
Brokers
2
BsUFA
2
Budget Cuts
2
Business Associates
2
C-Suite Executives
2
CA Supreme Court
2
CFDA
2
CFIUS
2
Childrens' Motrin
2
Chiropractors
2
Choice-of-Law
2
Cipro
2
CISO
2
Citizen Suits
2
Classification
2
Climate Action Plan
2
Clinical Evaluations
2
Closely Held Businesses
2
CLS Bank v Alice Corp
2
CMMI
2
Commercial General Liability Policies
2
Compelled Speech
2
Congressional Reports
2
Consent Decrees
2
Consolidated Appropriations Act
2
Conspiracies
2
Constitutional Challenges
2
Consumer Product Safety Improvement Act (CPSIA)
2
Consumers Legal Remedies Act
2
Contests & Promotions
2
Contingency Fees
2
Copyright Infringement
2
Corporate Taxes
2
Cost Recovery
Feedback? Tell us what you think of the new jdsupra.com!